4.4 Article

Identifying Patient and Provider-specific Gaps in Care Among Patients With Hepatitis B

Journal

JOURNAL OF CLINICAL GASTROENTEROLOGY
Volume 51, Issue 10, Pages 900-906

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MCG.0000000000000806

Keywords

Hepatitis B; care quality; care delivery; veterans administration

Funding

  1. United States National Institutes of Health [T32 DK007740-18]

Ask authors/readers for more resources

Goals: To examine patient, provider, and health system barriers to clinical follow-up among US veterans with chronic hepatitis B virus (HBV). Background: Studies have demonstrated deficiencies in clinical care and follow-up in HBV; however, patient, provider, and health-system barriers in non-Asian populations are understudied. Study: A retrospective cohort of 517 US veterans with chronic HBV at 3 diverse Veterans Affairs sites from 1999 to 2015. Laboratory testing and completion of clinical appointments were collected for 2 years following initial presentation. Results: Among HBV patients, 36% had drug abuse, 41% alcohol misuse, and 45% had psychiatric disorders. Patients had an average of 4.4 primary care visits within 2 years of the index hepatitis B surface antigen positive result, 38% had psychiatry visits, 21% had a psychiatric hospitalization; 26% saw gastroenterology/hepatology specialists. Within 1 year of the index hepatitis B surface antigen positive result, 75% had alanine aminotransferase testing, 14% had HBV entered into the problem list, and 8% had serologic confirmation. In multivariable analyses, cirrhosis [odds ratio (OR)=3.42; 95% confidence interval (CI), 1.84-6.36] was associated with higher odds of appropriate laboratory testing, alcohol misuse (OR=0.45; 95% CI, 0.29-0.80) was associated lower odds. Cirrhosis (OR=2.03; 95% CI, 1.11-3.72) and >= 2 primary care visits per year (OR=1.06; 95% CI, 1.01-1.11) were associated with higher odds of completing gastroenterology/hepatology consultation, whereas >= 1 psychiatric hospitalization in 2 years was associated with lower odds (OR=0.53; 95% CI, 0.34-0.82). Conclusions: In a diverse cohort of veterans with high psychiatric comorbidity and substance abuse, important patient and provider factors influence appropriate follow-up care. Future studies should evaluate the impact of provider education and care coordination strategies in HBV.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Gastroenterology & Hepatology

Multicenter assessment of hypertension management among liver transplantation recipients

Sneha Chebrolu, Meaghan Phipps, Frederick Yao, Jennifer Lai, Elizabeth Verna, Marina Serper, Giuseppe Cullaro, Sumeet K. Asrani, Lisa B. VanWagner

LIVER TRANSPLANTATION (2023)

Article Gastroenterology & Hepatology

Patterns of Care Utilization and Hepatocellular Carcinoma Surveillance: Tracking Care Across the Pandemic

Marina Serper, Elliot B. B. Tapper, David E. E. Kaplan, Tamar H. H. Taddei, Nadim Mahmud

Summary: We examined the impact of the COVID-19 pandemic on mortality, outpatient, and inpatient care for cirrhosis patients. HCC surveillance rates initially dropped but have rebounded, although still below pre-pandemic levels. The use of population-based strategies and specialty care were associated with higher completion of HCC surveillance.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

Evaluation of Liver Disease in Pregnancy

Gres Karim, Dewan Giri, Tatyana Kushner, Nancy Reau

Summary: Liver disease in pregnancy encompasses a wide range of liver conditions that need to be identified early to provide appropriate care. Evaluation should include careful testing to rule out chronic liver disease, coincidental liver injury, and pregnancy-specific liver injury. Early recognition and management of liver disease in pregnancy are crucial for optimizing outcomes for both mother and baby, and for facilitating referrals to liver specialists and postnatal care if necessary.

CLINICS IN LIVER DISEASE (2023)

Review Gastroenterology & Hepatology

Health disparities in chronic liver disease

Ani Kardashian, Marina Serper, Norah Terrault, Lauren D. Nephew

Summary: The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Understanding how social and structural factors cause health disparities and affect chronic liver disease outcomes is crucial for improving liver health outcomes.

HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Nonselective beta blockers, hepatic decompensation, and mortality in cirrhosis: A national cohort study

Marina Serper, David E. Kaplan, Tamar H. Taddei, Elliot B. Tapper, Jordana B. Cohen, Nadim Mahmud

Summary: This study investigated the effectiveness of nonselective beta blockers in preventing hepatic decompensation and liver-related mortality. The results suggest that carvedilol may reduce the risk of hepatic decompensation and composite outcome of hepatic decompensation/liver-related mortality, especially in specific subgroups.

HEPATOLOGY (2023)

Editorial Material Gastroenterology & Hepatology

A novel method using the level of mobility to predict mortality in patients admitted for decompensated cirrhosis: A prospective study

Andrew J. Groff, Marina Serper, Sunny Y. Tao, Pamela M. Bloomer, Michael A. Dunn, Andres Duarte-Rojo

LIVER TRANSPLANTATION (2023)

Article Surgery

Racial and ethnic disparities in psychosocial evaluation and liver transplant waitlisting

Sasha Deutsch-Link, Therese Bittermann, Lauren Nephew, Katherine Ross-Driscoll, Ethan M. Weinberg, Robert M. Weinrieb, Kim M. Olthoff, Senayish Addis, Marina Serper

Summary: This study aimed to investigate racial and ethnic inequities in liver transplantation (LT) waitlisting for medical and psychosocial reasons. The findings showed that Black race and Hispanic/Latinx ethnicity were associated with not being waitlisted for psychosocial reasons. Health systems and LT centers should develop programs to address these disparities and promote equity in LT access.

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Review Gastroenterology & Hepatology

Delta hepatitis epidemiology and the global burden of disease

Tatyana Kushner

Summary: Delta Hepatitis, the most severe form of hepatitis, has varying prevalence, genotype distribution, and risk factors worldwide. Limited knowledge exists about its global epidemiology due to inconsistent screening practices for HDV. This article summarizes the current understanding of testing prevalence and HDV positivity globally.

JOURNAL OF VIRAL HEPATITIS (2023)

Article Immunology

Modeling-Based Response-Guided Hepatitis C Treatment During Pregnancy and Postpartum

Tatyana Kushner, Custon T. Nyabanga, Scott J. Cotler, Ohad Etzion, Harel Dahari

Summary: Treating hepatitis C virus (HCV) during pregnancy can address HCV during prenatal care and potentially reduce the risk of vertical transmission. Response-guided therapy provides a way to customize and shorten HCV treatment duration during pregnancy. Data from a 27-year-old woman showed that HCV was stable before treatment and dropped in a biphasic manner during sofosbuvir/velpatasvir therapy, reaching undetectable levels at delivery-16 days after starting therapy. Mathematical modeling predicted that a cure could have been achieved after 7 weeks of sofosbuvir/velpatasvir, reducing the therapy duration by 5 weeks.

OPEN FORUM INFECTIOUS DISEASES (2023)

Article Obstetrics & Gynecology

Transient elastography and controlled attenuation parameter to evaluate hepatic steatosis and liver stiffness in postpartum patients

Farrah Naz Hussain, Emma Rosenbluth, Kristina Martimucci Feldman, Tirtza Spiegel Strauss, Emily Schneider, Emily Schmidt-Beauchat, Clara Rodriguez-Rivas, Lois Brustman, Tatyana Kushner

Summary: The aim of this study was to assess the prevalence of elevated liver stiffness and steatosis immediately postpartum and to determine whether there were differences in rates of metabolic disorders of pregnancy and pre-pregnancy conditions in those with elevated liver stiffness/liver steatosis.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2023)

Letter Gastroenterology & Hepatology

Predictive performance of CAR-OLT and CAD-LT scores for post-transplant adverse cardiovascular events in a large transplant center

Helen Tang, Christopher Shi, Sara Chapin, Sarjukumar Panchal, Xiaoling Yu, Lisa B. B. VanWagner, Marina Serper, Nadim Mahmud

LIVER TRANSPLANTATION (2023)

Review Gastroenterology & Hepatology

Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: A systematic review and meta-analysis

Marcia Lange, Devika Nadkarni, Lily Martin, Carolyn Newberry, Sonal Kumar, Tatyana Kushner

Summary: Despite the lack of FDA-approved treatments for NAFLD, intermittent fasting shows promising results in improving hepatic endpoints and promoting weight loss in adults with NAFLD. However, further large-scale randomized controlled studies are needed to validate these findings.

HEPATOLOGY COMMUNICATIONS (2023)

Article Gastroenterology & Hepatology

Aspirin is associated with a reduced incidence of liver disease in men

Mara Sophie Vell, Arunkumar Krishnan, Kirk Wangensteen, Marina Serper, Katharina Sophie Seeling, Leonida Hehl, Miriam Daphne Rendel, Inuk Zandvakili, Marijana Vujkovic, Eleonora Scorletti, Kate Townsend Creasy, Christian Trautwein, Daniel James Rader, Saleh Alqahtani, Kai Markus Schneider, Carolin Victoria Schneider

Summary: Regular aspirin use is associated with a reduced risk of liver disease in men without an elevated risk of gastrointestinal bleeding or ulcers. The protective effect of aspirin appears to be dependent on the duration of intake, and there may be sex-related differences in its effects.

HEPATOLOGY COMMUNICATIONS (2023)

Article Pediatrics

Evaluation of 2-year outcomes in infants born to mothers with and without NAFLD in pregnancy

Aliza Gross, Marcia Lange, Emma Rosenbluth, Carin Carroll, Rhoda Sperling, Courtney Juliano, Keith Sigel, Scott L. Friedman, Pamela A. Argiriadi, Jaime Chu, Tatyana Kushner

Summary: This study found that maternal nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of very premature delivery before 32 weeks and neonatal jaundice. However, it does not have a significant impact on infant growth and weight over the first 2 years of life.

EUROPEAN JOURNAL OF PEDIATRICS (2023)

Article Gastroenterology & Hepatology

HCC is associated with diabetes and longitudinal blood glucose control in a national cohort with cirrhosis

Catherine Mezzacappa, Nadim Mahmud, Marina Serper, Binu V. John, Tamar H. Taddei, David E. Kaplan

Summary: Diabetes is associated with hepatocellular carcinoma (HCC) in patients with cirrhosis, and inadequate long-term blood glucose control is consistently associated with a higher risk of HCC.

HEPATOLOGY COMMUNICATIONS (2023)

No Data Available